Murce E - Search Results

1

3p-C-NETA: A versatile and effective chelator for development of Al¹⁸F-labeled and therapeutic radiopharmaceuticals.

Ahenkorah S, Murce E, Cawthorne C, Ketchemen JP, Deroose CM, Cardinaels T, Seimbille Y, Fonge H, Gsell W, Bormans G, Ooms M, Cleeren F. Ahenkorah S, et al. Among authors: murce e. Theranostics. 2022 Aug 8;12(13):5971-5985. doi: 10.7150/thno.75336. eCollection 2022. Theranostics. 2022. PMID: 35966589 Free PMC article.

2

Synthesis and radiolabelling of PSMA-targeted derivatives containing GYK/MVK cleavable linkers.

Murce E, de Blois E, van den Berg S, de Jong M, Seimbille Y. Murce E, et al. R Soc Open Sci. 2023 Mar 8;10(3):220950. doi: 10.1098/rsos.220950. eCollection 2023 Mar. R Soc Open Sci. 2023. PMID: 36908985 Free PMC article.

3

Direct comparison of [¹⁸F]AlF-NOTA-JR11 and [¹⁸F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist.

Ahenkorah S, Cawthorne C, Murce E, Deroose CM, Cardinaels T, Seimbille Y, Bormans G, Ooms M, Cleeren F. Ahenkorah S, et al. Among authors: murce e. Nucl Med Biol. 2023 Mar-Apr;118-119:108338. doi: 10.1016/j.nucmedbio.2023.108338. Epub 2023 Mar 29. Nucl Med Biol. 2023. PMID: 37018875 Free article.

4

Preclinical Evaluation of a PSMA-Targeting Homodimer with an Optimized Linker for Imaging of Prostate Cancer.

Murce E, Beekman S, Spaan E, Handula M, Stuurman D, de Ridder C, Seimbille Y. Murce E, et al. Molecules. 2023 May 11;28(10):4022. doi: 10.3390/molecules28104022. Molecules. 2023. PMID: 37241763 Free PMC article.

5

Radiochemical and Biological Evaluation of 3p-C-NETA-ePSMA-16, a Promising PSMA-Targeting Agent for Radiotheranostics.

Murce E, Ahenkorah S, Beekman S, Handula M, Stuurman D, de Ridder C, Cleeren F, Seimbille Y. Murce E, et al. Pharmaceuticals (Basel). 2023 Jun 15;16(6):882. doi: 10.3390/ph16060882. Pharmaceuticals (Basel). 2023. PMID: 37375829 Free PMC article.

6

eTFC-01: a dual-labeled chelate-bridged tracer for SSTR2-positive tumors.

Chapeau D, Beekman S, Handula M, Murce E, de Ridder C, Stuurman D, Seimbille Y. Chapeau D, et al. Among authors: murce e. EJNMMI Radiopharm Chem. 2024 May 22;9(1):44. doi: 10.1186/s41181-024-00272-0. EJNMMI Radiopharm Chem. 2024. PMID: 38775990 Free PMC article.

7

Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer.

Murce E, Spaan E, Beekman S, van den Brink L, Handula M, Stuurman D, de Ridder C, Dalm SU, Seimbille Y. Murce E, et al. Pharmaceuticals (Basel). 2023 Jul 28;16(8):1072. doi: 10.3390/ph16081072. Pharmaceuticals (Basel). 2023. PMID: 37630990 Free PMC article.

8

Chloroquine analogs as antimalarial candidates with potent in vitro and in vivo activity.

Aguiar ACC, Murce E, Cortopassi WA, Pimentel AS, Almeida MMFS, Barros DCS, Guedes JS, Meneghetti MR, Krettli AU. Aguiar ACC, et al. Among authors: murce e. Int J Parasitol Drugs Drug Resist. 2018 Dec;8(3):459-464. doi: 10.1016/j.ijpddr.2018.10.002. Epub 2018 Oct 13. Int J Parasitol Drugs Drug Resist. 2018. PMID: 30396013 Free PMC article.

9

Structure-based de novo design, molecular docking and molecular dynamics of primaquine analogues acting as quinone reductase II inhibitors.

Murce E, Cuya-Guizado TR, Padilla-Chavarria HI, França TCC, Pimentel AS. Murce E, et al. J Mol Graph Model. 2015 Nov;62:235-244. doi: 10.1016/j.jmgm.2015.10.001. Epub 2015 Oct 17. J Mol Graph Model. 2015. PMID: 26521207

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page